Related Experiment Video
Updated: Jan 28, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
CDC20 contributes to the development of human cutaneous squamous cell carcinoma through the Wnt/β‑catenin signaling
Zhaowei Chu1, Xinyue Zhang1, Qingyan Li1
1Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Abstract:
Cell division cycle 20 (CDC20) is a regulatory molecule and serves critical roles at multiple points of the cell cycle. Recent evidence indicates that CDC20 may serve an oncogenic role in a number of human cancer types. However, the role of CDC20 in primary cutaneous squamous cell carcinoma (cSCC) has not been studied, to the best of our knowledge. The aim of the present study was to investigate whether and how CDC20 is involved in the tumorigenesis of cSCC. The results revealed that CDC20 expression was significantly increased in cSCC tissues and cell lines, and its expression was associated with pathological differentiation. Downregulation of CDC20 inhibited cell proliferation, induced cell cycle arrest, promoted apoptosis and reduced migratory ability through inhibition of the Wnt/β‑catenin signaling pathway. Furthermore, all‑trans‑retinoic acid treatment significantly downregulated CDC20 expression in cSCC. The present results revealed that CDC20 may serve a crucial role in human cSCC, and suggested that CDC20 may be a novel biomarker for the prevention, diagnosis and treatment of cSCC.
Insights
Cell division cycle 20 (CDC20) is upregulated in cutaneous squamous cell carcinoma (cSCC), driving tumor growth and migration. Targeting CDC20 may offer a new therapeutic strategy for cSCC.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cell division cycle 20 (CDC20) is a key cell cycle regulator.
- CDC20 has an oncogenic role in various human cancers.
- The role of CDC20 in cutaneous squamous cell carcinoma (cSCC) remains uninvestigated.
Purpose of the Study:
- To investigate the role and mechanism of CDC20 in cSCC tumorigenesis.
- To determine if CDC20 expression correlates with cSCC pathological differentiation.
Main Methods:
- Quantitative analysis of CDC20 expression in cSCC tissues and cell lines.
- Functional assays assessing the impact of CDC20 downregulation on cell proliferation, cell cycle, apoptosis, and migration.
- Investigation of CDC20's effect on the Wnt/β‑catenin signaling pathway.
- Assessment of all‑trans‑retinoic acid's effect on CDC20 expression in cSCC.
Main Results:
- CDC20 expression is significantly increased in cSCC tissues and cell lines.
- Elevated CDC20 expression correlates with pathological differentiation in cSCC.
- CDC20 downregulation inhibits proliferation, induces cell cycle arrest, promotes apoptosis, and reduces migration via Wnt/β‑catenin pathway inhibition.
- All‑trans‑retinoic acid treatment downregulates CDC20 expression in cSCC.
Conclusions:
- CDC20 plays a critical role in human cSCC tumorigenesis.
- CDC20 inhibition presents a potential therapeutic strategy for cSCC.
- CDC20 may serve as a novel biomarker for cSCC prevention, diagnosis, and treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
TGF - β Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway

